MANNKIND, CORP.

Follow

Organization

Westlake Village, CA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Methods for the synthesis of activated ethylfumarates and their use...
- Patent number 11,479,535
- Issue date Oct 25, 2022
- MANNKIND, CORP.
- Kelly Sullivan Kraft
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Formation of N-protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine
- Patent number 11,440,891
- Issue date Sep 13, 2022
- MANNKIND, CORP.
- John J. Freeman
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazin...
- Patent number 10,870,628
- Issue date Dec 22, 2020
- MANNKIND, CORP.
- John J. Freeman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for the synthesis of activated ethylfumarates and their use...
- Patent number 10,858,325
- Issue date Dec 8, 2020
- MANNKIND, CORP.
- Kelly Sullivan Kraft
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Formation of N-protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine
- Patent number 10,640,471
- Issue date May 5, 2020
- MANNKIND, CORP.
- John J. Freeman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazin...
- Patent number 10,577,331
- Issue date Mar 3, 2020
- MANNKIND, CORP.
- John J. Freeman
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
INHALED IMATINIB FOR PULMONARY HYPERTENSION
- Publication number 20220152025
- Publication date May 19, 2022
- United Therapeutics Corporation
- Adam Marc Silverstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks